chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Constipation, Fatigue, Fluid retention, Headache
Clinical narrative: Accumulating fluid starting; swelling and accumulating fluid; constipation; Chills; arm pain; body aches; glands under neck swelled/glands under right arm swelled; extremely tired; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), FLUID RETENTION (Accumulating fluid starting), SWELLING (swelling and accumulating fluid), MYALGIA (body aches) and LYMPHADENOPATHY (glands under neck swelled/glands under right arm swelled) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical History reported by the reporter.  Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), TELMISARTAN, VERAPAMIL and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain), MYALGIA (body aches), LYMPHADENOPATHY (glands under neck swelled/glands under right arm swelled), FATIGUE (extremely tired) and HEADACHE (headache). On 25-Feb-2021, the patient experienced CONSTIPATION (constipation) and CHILLS (Chills). On 08-Mar-2021, the patient experienced SWELLING (swelling and accumulating fluid). On 13-Mar-2021, the patient experienced FLUID RETENTION (Accumulating fluid starting). On 02-Mar-2021, CONSTIPATION (constipation) and CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), FLUID RETENTION (Accumulating fluid starting), SWELLING (swelling and accumulating fluid), MYALGIA (body aches), LYMPHADENOPATHY (glands under neck swelled/glands under right arm swelled), FATIGUE (extremely tired) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Platelet count: elevated (High) Elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.       Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: Follow-up received on 17-MAR-2021; Lab data Added, New events updated
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Pain in extremity, Platelet count, Swelling
Clinical narrative: Accumulating fluid starting; swelling and accumulating fluid; constipation; Chills; arm pain; body aches; glands under neck swelled/glands under right arm swelled; extremely tired; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), FLUID RETENTION (Accumulating fluid starting), SWELLING (swelling and accumulating fluid), MYALGIA (body aches) and LYMPHADENOPATHY (glands under neck swelled/glands under right arm swelled) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical History reported by the reporter.  Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), TELMISARTAN, VERAPAMIL and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain), MYALGIA (body aches), LYMPHADENOPATHY (glands under neck swelled/glands under right arm swelled), FATIGUE (extremely tired) and HEADACHE (headache). On 25-Feb-2021, the patient experienced CONSTIPATION (constipation) and CHILLS (Chills). On 08-Mar-2021, the patient experienced SWELLING (swelling and accumulating fluid). On 13-Mar-2021, the patient experienced FLUID RETENTION (Accumulating fluid starting). On 02-Mar-2021, CONSTIPATION (constipation) and CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), FLUID RETENTION (Accumulating fluid starting), SWELLING (swelling and accumulating fluid), MYALGIA (body aches), LYMPHADENOPATHY (glands under neck swelled/glands under right arm swelled), FATIGUE (extremely tired) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Platelet count: elevated (High) Elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.       Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: Follow-up received on 17-MAR-2021; Lab data Added, New events updated
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: it is read and itchy; rash on the injection side around 1,5 inches; it is read; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (it is read and itchy), VACCINATION SITE RASH (rash on the injection side around 1,5 inches) and VACCINATION SITE ERYTHEMA (it is read) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Thyroid disorder NOS. Concomitant products included AMLODIPINE and CANDESARTAN for Blood pressure, ALOPURINOL for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (it is read and itchy), VACCINATION SITE RASH (rash on the injection side around 1,5 inches) and VACCINATION SITE ERYTHEMA (it is read). At the time of the report, VACCINATION SITE PRURITUS (it is read and itchy), VACCINATION SITE RASH (rash on the injection side around 1,5 inches) and VACCINATION SITE ERYTHEMA (it is read) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included thyroid medication. Treatment medications include a cream for the itchiness.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up received on 04-MAY-2021 contains updated event outcome to recovered from not recovered
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: about less than half of vaccine suspension was not administered-leaked out of cap to syringe; about less than half of vaccine suspension was not administered-leaked out of cap to syringe; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (about less than half of vaccine suspension was not administered-leaked out of cap to syringe) and DEVICE CONNECTION ISSUE (about less than half of vaccine suspension was not administered-leaked out of cap to syringe) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 12-Mar-2021, the patient experienced UNDERDOSE (about less than half of vaccine suspension was not administered-leaked out of cap to syringe) and DEVICE CONNECTION ISSUE (about less than half of vaccine suspension was not administered-leaked out of cap to syringe). On 12-Mar-2021, UNDERDOSE (about less than half of vaccine suspension was not administered-leaked out of cap to syringe) and DEVICE CONNECTION ISSUE (about less than half of vaccine suspension was not administered-leaked out of cap to syringe) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Pyrexia
Clinical narrative: loose stool; fever; chills; A spontaneous report was received from a consumer concerning a 87-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events fever, chills and loose stool.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 07 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 032M20A) Intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 08 Mar 2021, the patient experienced the event(s) fever, chills and loose stool.  Treatment details included pepto-bismol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), fever, chills and loose stool were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: Fever - Temperature of 99.6F; Chills; Arm Pain - Near Injection Site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever - Temperature of 99.6F), CHILLS (Chills), VACCINATION SITE PAIN (Arm Pain - Near Injection Site) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Fever - Temperature of 99.6F), CHILLS (Chills), VACCINATION SITE PAIN (Arm Pain - Near Injection Site) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever - Temperature of 99.6F), CHILLS (Chills), VACCINATION SITE PAIN (Arm Pain - Near Injection Site) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was reported. Patient had temperature 99.6 F.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site warmth
Clinical narrative: Warm to touch at injection site; Redness at injection site about 2 inches long; Lump at injection site; A spontaneous report  was received from a consumer concerning a 58-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced lump, redness at injection site about 2 inches long and warm to touch at injection site.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 02 Mar 2021, prior to the onset of the events, the patient received first of two planned doses of mRNA-1273 (lot/batch: 014M20A) Intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 03 Mar 2021, the patient experienced lump at injection site (episode 1), redness at injection site about 2 inches long (episode 1) which was there over a weekend and went away. On 12 Mar 2021, the patient again experienced same redness (episode 2), lump (episode 2) little bigger and warm to touch at injection site. No treatment information provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events lump at injection site (episode 1) and redness at injection site about 2 inches long (episode 1) was resolved on 08 Mar 2021. The outcome of redness at injection site (episode 2), lump at injection site (episode 2) and  warm to touch at injection site was not reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Extremally sleepy, went to her house did not eat and went straight to bed; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Extremally sleepy, went to her house did not eat and went straight to bed) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012620A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced SOMNOLENCE (Extremally sleepy, went to her house did not eat and went straight to bed). At the time of the report, SOMNOLENCE (Extremally sleepy, went to her house did not eat and went straight to bed) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications includes  medication for the shaking on her arm and leg when she goes to sleep, after the brain surgery. No treatment related information has been reported.     Most recent FOLLOW-UP information incorporated above includes: On 19-Mar-2021: TCR Document received on 14-JUN-2021 Contains event outcome updated.
Age: 63.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site swelling
Clinical narrative: swelling at injection; fever 102F; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling at injection), PYREXIA (fever 102F) and CHILLS (chills) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at injection), PYREXIA (fever 102F) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (swelling at injection), PYREXIA (fever 102F) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: injection site was swollen; has a rash on the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE RASH (has a rash on the arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE RASH (has a rash on the arm). At the time of the report, VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE RASH (has a rash on the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment details included None.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Raynaud's phenomenon
Clinical narrative: Raynaud syndrome; Chills; Headache; Fatigue (feels like hit by a truck); A spontaneous report (United States) was received from a consumer concerning a 73-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills (Chills), headache (Headache),fatigue (feels like hit by a truck) (Fatigue) and Raynaud syndrome (Raynaud's phenomenon).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 03 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 027A21A) Intramuscularly for prophylaxis of COVID-19 infection.  On 03 Mar 2021, the patient experienced the events chills, headache, fatigue (feels like hit by a truck) and Raynaud syndrome (Raynaud's phenomenon).  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On 4 Mar 2021 the outcome of events, chills and headache was resolved.  The outcome of events, fatigue (feels like hit by a truck) and Raynaud syndrome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vials not stored properly may have been administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vials not stored properly may have been administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials not stored properly may have been administered). At the time of the report, PRODUCT STORAGE ERROR (Vials not stored properly may have been administered) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was unknown by the reporter.  On an unknown date, vaccines being stored had 17 temperature readings that were over 28F. 50 doses of this vaccine were given to patients after the temperature excursion. No other information was provided regarding the 50 patients.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received and reporter information and event information updated.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram neck, Headache, Hypersensitivity, Neck mass, Pruritus
Clinical narrative: Lump on the left side of her neck; Arms and back itch like crazy; Redness on her arm below injection site; Headache; Hypersensitivity reaction; Lumps in my neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK MASS (Lump on the left side of her neck), PRURITUS (Arms and back itch like crazy), VACCINATION SITE ERYTHEMA (Redness on her arm below injection site), HEADACHE (Headache) and HYPERSENSITIVITY (Hypersensitivity reaction) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L30A and 029L20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: TETANUS VACCINE (Rash) in 1962. Concurrent medical conditions included Penicillin allergy (Rash) in July 1995, Cholesterol, Hypertension and Reflux esophagitis. Concomitant products included ATORVASTATIN for Cholesterol, LISINOPRIL for Hypertension, OMEPRAZOLE for Reflux esophagitis, CENTRUM FOR WOMEN for Supplementation therapy, ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D), VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and ELDERBERRY [SAMBUCUS NIGRA] for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced NECK MASS (Lump on the left side of her neck), PRURITUS (Arms and back itch like crazy), VACCINATION SITE ERYTHEMA (Redness on her arm below injection site), HEADACHE (Headache), HYPERSENSITIVITY (Hypersensitivity reaction) and SWELLING (Lumps in my neck). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. In March 2021, PRURITUS (Arms and back itch like crazy), VACCINATION SITE ERYTHEMA (Redness on her arm below injection site), HEADACHE (Headache) and HYPERSENSITIVITY (Hypersensitivity reaction) had resolved, SWELLING (Lumps in my neck) had not resolved. At the time of the report, NECK MASS (Lump on the left side of her neck) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram neck: (Inconclusive) Specialist doctor did not find anything worrisome at this time.. On an unknown date, Ultrasound scan: Inconclusive and Inconclusive.         Patient reported that Doctor - regular doctor - wants that she has a future ultrasounds to check lumps as they still  there.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jun-2021: Follow up was received and included information for Product tab 1st dose, Patient tab, race, ethnic group, height, weight, allergies, historical condition, concomitant medication, onset date, stop date, and outcome event.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Ultrasound scan, Vaccination site erythema
Clinical narrative: Lump on the left side of her neck; Arms and back itch like crazy; Redness on her arm below injection site; Headache; Hypersensitivity reaction; Lumps in my neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK MASS (Lump on the left side of her neck), PRURITUS (Arms and back itch like crazy), VACCINATION SITE ERYTHEMA (Redness on her arm below injection site), HEADACHE (Headache) and HYPERSENSITIVITY (Hypersensitivity reaction) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L30A and 029L20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: TETANUS VACCINE (Rash) in 1962. Concurrent medical conditions included Penicillin allergy (Rash) in July 1995, Cholesterol, Hypertension and Reflux esophagitis. Concomitant products included ATORVASTATIN for Cholesterol, LISINOPRIL for Hypertension, OMEPRAZOLE for Reflux esophagitis, CENTRUM FOR WOMEN for Supplementation therapy, ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D), VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and ELDERBERRY [SAMBUCUS NIGRA] for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced NECK MASS (Lump on the left side of her neck), PRURITUS (Arms and back itch like crazy), VACCINATION SITE ERYTHEMA (Redness on her arm below injection site), HEADACHE (Headache), HYPERSENSITIVITY (Hypersensitivity reaction) and SWELLING (Lumps in my neck). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. In March 2021, PRURITUS (Arms and back itch like crazy), VACCINATION SITE ERYTHEMA (Redness on her arm below injection site), HEADACHE (Headache) and HYPERSENSITIVITY (Hypersensitivity reaction) had resolved, SWELLING (Lumps in my neck) had not resolved. At the time of the report, NECK MASS (Lump on the left side of her neck) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram neck: (Inconclusive) Specialist doctor did not find anything worrisome at this time.. On an unknown date, Ultrasound scan: Inconclusive and Inconclusive.         Patient reported that Doctor - regular doctor - wants that she has a future ultrasounds to check lumps as they still  there.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jun-2021: Follow up was received and included information for Product tab 1st dose, Patient tab, race, ethnic group, height, weight, allergies, historical condition, concomitant medication, onset date, stop date, and outcome event.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Pelvic pain
Clinical narrative: flu-like symptoms; body aches/muscle pain; sharp pain in pelvic area; This spontaneous case was reported by a consumer and describes the occurrence of PELVIC PAIN (sharp pain in pelvic area), INFLUENZA LIKE ILLNESS (flu-like symptoms) and MYALGIA (body aches/muscle pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PELVIC PAIN (sharp pain in pelvic area). On 05-Mar-2021, the patient experienced MYALGIA (body aches/muscle pain). On 06-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, PELVIC PAIN (sharp pain in pelvic area), INFLUENZA LIKE ILLNESS (flu-like symptoms) and MYALGIA (body aches/muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: the patient (female) who received 1st dose was exposed to COVID; A spontaneous report was received from a pharmacist concerning a 47 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events patient (female) who received 1st dose was exposed to covid.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 18 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (Batch: Not provided) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient who received 1st dose was exposed to COVID. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not provided.  The outcome of event patient (female) who received 1st dose was exposed to covid was not reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Rash, Urticaria
Clinical narrative: arm swollen and red; arm swollen and red; rash in her hands in between the fingers and palms/rash is down the arm, neck and head, around the face, chest and back, around the waist, and down the legs;; little bumps almost like ant bites; itch real badly; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swollen and red), RASH (rash in her hands in between the fingers and palms/rash is down the arm, neck and head, around the face, chest and back, around the waist, and down the legs;), URTICARIA (little bumps almost like ant bites), PRURITUS (itch real badly) and ERYTHEMA (arm swollen and red) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 09-Mar-2021, the patient experienced RASH (rash in her hands in between the fingers and palms/rash is down the arm, neck and head, around the face, chest and back, around the waist, and down the legs;), URTICARIA (little bumps almost like ant bites) and PRURITUS (itch real badly). On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swollen and red) and ERYTHEMA (arm swollen and red). The patient was treated with HYDROCORTISONE ACETATE (CORTAIDE) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 12-Mar-2021, PRURITUS (itch real badly) had resolved. At the time of the report, PERIPHERAL SWELLING (arm swollen and red) and ERYTHEMA (arm swollen and red) had resolved, RASH (rash in her hands in between the fingers and palms/rash is down the arm, neck and head, around the face, chest and back, around the waist, and down the legs;) outcome was unknown and URTICARIA (little bumps almost like ant bites) had not resolved. Not Provided
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Muscle disorder, Tremor
Clinical narrative: LOSS OF BACK MUSCLE CONTROL; Fatigue; Started shaking violently for 2 - 3 hours; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE DISORDER (LOSS OF BACK MUSCLE CONTROL), TREMOR (Started shaking violently for 2 - 3 hours) and FATIGUE (Fatigue) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A2VA and OBM2OA) for COVID-19 vaccination.     NO MEDICAL HISTORY WAS GIVEN.  Concurrent medical conditions included Blood pressure high (No medical history reported) since 04-Nov-2012, Diabetes since 01-Apr-2016, Chronic bronchitis since 01-Oct-2011 and Reflux gastritis since 01-Jul-2014. Concomitant products included METOPROLOL TARTRATE from 01-Nov-2012 to an unknown date and LISINOPRIL from 01-Nov-2012 to an unknown date for Blood pressure, CETIRIZINE HCL from 01-Oct-2011 to an unknown date for Chronic bronchitis, EMPAGLIFLOZIN from 01-Apr-2016 to an unknown date for Diabetes, OMEPRAZOLE from 01-Jul-2014 to an unknown date for Reflux gastritis.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced TREMOR (Started shaking violently for 2 - 3 hours). On 10-Mar-2021, the patient experienced MUSCLE DISORDER (LOSS OF BACK MUSCLE CONTROL) and FATIGUE (Fatigue). On 10-Mar-2021, TREMOR (Started shaking violently for 2 - 3 hours) had resolved. On 11-Mar-2021, MUSCLE DISORDER (LOSS OF BACK MUSCLE CONTROL) had resolved. On 12-Mar-2021, FATIGUE (Fatigue) had resolved.            Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: New events, and events outcome were updated. Concomitant products were added. Lot number was added.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot at injection site; 2.5 inches in diameter of redness in injection site; Soreness at injection site; Swelling at injection site/injection site raised; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE SWELLING (Swelling at injection site/injection site raised) and VACCINATION SITE ERYTHEMA (2.5 inches in diameter of redness in injection site) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site/injection site raised). On 11-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot at injection site) and VACCINATION SITE ERYTHEMA (2.5 inches in diameter of redness in injection site). At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE SWELLING (Swelling at injection site/injection site raised) and VACCINATION SITE ERYTHEMA (2.5 inches in diameter of redness in injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: terrible body aches from her head to her toes; A spontaneous report (United States) was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event achy all over.  The patient's current condition included multiple sclerosis. No relevant concomitant medications were reported.  On an unknown date, patient received first of two planned doses of mRNA-1273 via unknown route in for prophylaxis of COVID-19 infection. On 11 Mar 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: 032M20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 11 Mar 2021, after taking mRNA-1273, the patient experienced the event(s) achy all over. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  On outcome of event, achy all over was reported as resolving.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pyrexia
Clinical narrative: No medical history information was provided.  Concomitant products included HYDROCHLOROTHIAZIDE, CARVEDILOL, SIMVASTATIN and ESCITALOPRAM for an unknown indication.  On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PYREXIA (102.2F fever). 12-Mar-2021, the patient experienced NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache in front of forehead) and VACCINATION SITE PAIN (Right arm of injection hurts). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, tid. At the time of the report, PYREXIA (102.2F fever), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache in front of forehead) and VACCINATION SITE PAIN (Right arm of injection hurts) outcome was unknown.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Body temperature: 102.2 (High) 102.2F fever.  The action taken with mRNA-1273 in response to the event was not applicable.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up information received on 04-Jun-2021 contains no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: No medical history information was provided.  Concomitant products included HYDROCHLOROTHIAZIDE, CARVEDILOL, SIMVASTATIN and ESCITALOPRAM for an unknown indication.  On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PYREXIA (102.2F fever). 12-Mar-2021, the patient experienced NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache in front of forehead) and VACCINATION SITE PAIN (Right arm of injection hurts). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, tid. At the time of the report, PYREXIA (102.2F fever), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache in front of forehead) and VACCINATION SITE PAIN (Right arm of injection hurts) outcome was unknown.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Body temperature: 102.2 (High) 102.2F fever.  The action taken with mRNA-1273 in response to the event was not applicable.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up information received on 04-Jun-2021 contains no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pregnancy, Pregnancy test positive
Clinical narrative: pregnant; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (pregnant) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included Hypertension (It has improved.) in January 2021, Pregnant (Number of Previous pregnancy-1) and Placental disorder (Low placental liquid at 40 week). Concurrent medical conditions included Penicillin allergy. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and IRON for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in December 2020 and the estimated date of delivery was 30-Sep-2021. On 12-Mar-2021, the patient experienced PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 12-Mar-2021, PREGNANCY (pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Pregnancy test positive: positive (Positive) Positive.         No treatment information was reported.  Other diagnostic tests included ultrasounds (normal) and glucose tolerance (levels were normal) on an unknown date.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Headache; Body chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Body chills) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 11-Mar-2021, the patient experienced PYREXIA (Fever). On 12-Mar-2021, the patient experienced HEADACHE (Headache) and CHILLS (Body chills). At the time of the report, HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Body chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Heart rate, Oral mucosal blistering, Vaccination site rash
Clinical narrative: mouth blister; rash on right arm started on day one; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (mouth blister) and VACCINATION SITE RASH (rash on right arm started on day one) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included IRON for Iron supplementation, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), BUDESONIDE, CROMOGLICATE SODIUM (NASALCROM), ASPIRIN [ACETYLSALICYLIC ACID], IPRATROPIUM, ALBUTEROL [SALBUTAMOL], VITAMIN D NOS, FOLIC ACID, FAMOTIDINE (PEPCID [FAMOTIDINE]), EPINEPHRINE (EPIPEN) and OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE RASH (rash on right arm started on day one). On 12-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ORAL MUCOSAL BLISTERING (mouth blister). The patient was treated with PREDNISOLONE at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ORAL MUCOSAL BLISTERING (mouth blister) and VACCINATION SITE RASH (rash on right arm started on day one) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Full blood count: pending (Inconclusive) pending. On an unknown date, Heart rate: elevated (High) Elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       In concomitant medications nasal spray was also included.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Rash erythematous, Rash pruritic
Clinical narrative: Anxiety aggravated; Rash worse and bright red arms, legs, back; Rash started little itchy inside arm inner; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety aggravated), RASH PRURITIC (Rash started little itchy inside arm inner) and RASH ERYTHEMATOUS (Rash worse and bright red arms, legs, back) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism, GERD, Seasonal allergy, Anxiety and Allergy to antibiotic (Erythromycin + tetracycline of moderna.). Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA 24 HOUR) for Allergy, ALPRAZOLAM (XANAX) for Anxiety, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for GERD, LEVOTHYROXINE SODIUM (L THYROXINE) for Hypothyroidism, ASCORBIC ACID (ESTER C [ASCORBIC ACID]) and SALBUTAMOL SULFATE (PROAIR DIGIHALER) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced RASH PRURITIC (Rash started little itchy inside arm inner). On 18-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Rash worse and bright red arms, legs, back). On an unknown date, the patient experienced ANXIETY (Anxiety aggravated). The patient was treated with CORTISONE for Rash, at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYTREC) at an unspecified dose and frequency and METHYLPREDNISOLONE (MEDROL DOSEPAK) from 20-Mar-2021 to 25-Mar-2021 at an unspecified dose and frequency. At the time of the report, ANXIETY (Anxiety aggravated) and RASH ERYTHEMATOUS (Rash worse and bright red arms, legs, back) outcome was unknown and RASH PRURITIC (Rash started little itchy inside arm inner) had not resolved.            Treatment information included Allergy pill for general allergies, but nothing specific Rash.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Follow-up information will be processed at the same time as the initial report. Follow-up provided patient details, medical history, concomitant medications, treatment information and details surrounding the events.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, Pain in extremity
Clinical narrative: Tested positive for Covid; sore arm; congestion; A spontaneous report was received from a consumer concerning a 51-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tested positive for covid, sore arm, congestion.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011A21A) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) Tested positive for Covid, sore arm, congestion.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), tested positive for covid, sore arm, congestion was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Erythema, Fatigue, Myalgia
Clinical narrative: Weakness; Redness on right arm more than left 10x10cm began to circle the arm; Fatigue; Myalgia; This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (Weakness), ERYTHEMA (Redness on right arm more than left 10x10cm began to circle the arm), FATIGUE (Fatigue) and MYALGIA (Myalgia) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced ASTHENIA (Weakness), ERYTHEMA (Redness on right arm more than left 10x10cm began to circle the arm), FATIGUE (Fatigue) and MYALGIA (Myalgia). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness), ERYTHEMA (Redness on right arm more than left 10x10cm began to circle the arm), FATIGUE (Fatigue) and MYALGIA (Myalgia) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, Influenza like illness, Loss of personal independence in daily activities
Clinical narrative: like flu symptoms; feeling unwell; has no energy; has no appetite; Can't do anything; felt like had fever but don't; tired and exhausted; little nauseous; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (like flu symptoms), MALAISE (feeling unwell), ASTHENIA (has no energy), DECREASED APPETITE (has no appetite) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do anything) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (like flu symptoms), MALAISE (feeling unwell), ASTHENIA (has no energy), DECREASED APPETITE (has no appetite), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do anything), PYREXIA (felt like had fever but don't), FATIGUE (tired and exhausted) and NAUSEA (little nauseous). At the time of the report, INFLUENZA LIKE ILLNESS (like flu symptoms), MALAISE (feeling unwell), ASTHENIA (has no energy), DECREASED APPETITE (has no appetite), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do anything), PYREXIA (felt like had fever but don't), FATIGUE (tired and exhausted) and NAUSEA (little nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.